Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Photocure
PHOCurrent price
52.8 NOK
+0.3 NOK (+0.57%)
Last closed
54.3 NOK
Company
www.photocure.com
ISIN
NO0010000045
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Oslo Stock Exchange
Capitalization
1 476 885 332 NOK
Yield for 12 month
+1.15 %
1Y
3Y
5Y
10Y
15Y
PHO
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira, as well as strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway. Address: Hoffsveien 4, Oslo, Norway, 0275
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 084.63 NOKP/E ratio
114.6809Dividend Yield
–Current Year
+506 101 551 NOK
Last Year
+397 407 245 NOK
Current Quarter
+147 030 728 NOK
Last Quarter
+119 317 601 NOK
Current Year
+479 681 326 NOK
Last Year
+374 463 409 NOK
Current Quarter
+139 317 758 NOK
Last Quarter
+111 491 409 NOK
Key Figures PHO
1 year
3 years
5 years
10 years
EBITDA
58 767 212 NOK
Operating Margin TTM
PE Ratio
114.6809
Return On Assets TTM
3.52 %
PEG Ratio
–
Return On Equity TTM
2.66 %
Wall Street Target Price
1 084.63 NOK
Revenue TTM
519 163 053 NOK
Book Value
18.63 NOK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
0.8 %
Dividend Yield
–
Gross Profit TTM
374 463 415 NOK
Earnings per share
0.48 NOK
Diluted Eps TTM
0.48 NOK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
181.3 %
Profit Margin
2.5 %
Dividend Analytics PHO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PHO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
23.05.2013
Forward Annual Dividend Yield
–
Last Split Factor
515:504
Payout Ratio
–
Last Split Date
25.01.2006
Dividend Date
–
Stock Valuation PHO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
114.6809
Forward PE
121.9512
Enterprise Value Revenue
2.3196
Price Sales TTM
2.8395
Enterprise Value EBITDA
15.0604
Price Book MRQ
2.9185
Financials PHO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHO
For 52 weeks
47.51 NOK
72.68 NOK
50 Day MA
52.46 NOK
Shares Short Prior Month
–
200 Day MA
56.62 NOK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart